2024 - Announcements and Circulars - INVESTORS - Laekna

INVESTOR RELATIONS

CURE FOR A BETTER FUTURE

Scroll down to see more

Announcements and Circulars

2024 2023

May 10, 2024

[VOLUNTARY ANNOUNCEMENT] - INVESTIGATIONAL NEW DRUG APPROVAL FOR LAE102 FOR THE TREATMENT OF OBESITY WAS OBTAINED FROM THE CENTRE FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
More
May 07, 2024

[Monthly Returns] - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
More
April 26, 2024

[Environmental, Social and Governance Information/Report] - 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
More
April 15, 2024

[VOLUNTARY ANNOUNCEMENT] - INVESTIGATIONAL NEW DRUG APPROVAL FOR LAE102 FOR THE TREATMENT OF OBESITY WAS OBTAINED FROM THE U.S. FOOD AND DRUG ADMINISTRATION
More
April 03, 2024

[Monthly Returns] - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
More
March 26, 2024

Announcements and Notices - [Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
More

<1 2 3 4 5 6 7 >

RSS Feeds

If you want to know more about Laekna, please fill in the form below and sign up for emails:

Follow us on Linkedin

Copyright © Laekna Therapeutics, All Rights Reserved. 沪ICP备17047795号 Privacy Policy

Follow us on Linkedin

Follow us on Wechat